Skip to content
Al-Shaker for Scientific and Medical Supplies
1 / 3

Reference: GF1007F / KL1007F / GF617F

MacConkey Agar

Selective and differential agar for Gram-negative enteric bacilli, offered in a general formulation (ISO 21567) and a pharmaceutical formulation for Escherichia coli.

Key specifications

Product code (general, dehydrated)
GF1007F
Product code (general, granulated)
KL1007F
Product code (pharmaceutical, dehydrated)
GF617F
Form
Dehydrated powder (GF1007F, GF617F) and granulated (KL1007F)
  • Configured to your application by our specialists
  • Installed and commissioned on site
  • Training and after-sales support across Jordan, the GCC and MENA

Overview

Product overview

MacConkey Agar from Biocomma is supplied in two formulations. GF1007F (dehydrated) and KL1007F (granulated) are intended for isolating and differentiating lactose-fermenting from lactose-non-fermenting Gram-negative enteric bacilli and cite ISO 21567. GF617F is a separate pharmaceutical formulation listed for the selective isolation of Escherichia coli in pharmaceutical products (CP/EP/USP).

All versions rely on bile salts, neutral red and crystal violet, with lactose as the differentiating carbohydrate, and give a final pH of 7.1±0.2. The general version is prepared at 51.5 g per litre and the pharmaceutical version at 50.0 g per litre; both are boiled to dissolve and autoclaved at 121 °C for 15 minutes.

Specifications

Technical specifications

26 parameters

Identification

Product code (general, dehydrated)
GF1007F
Product code (general, granulated)
KL1007F
Product code (pharmaceutical, dehydrated)
GF617F
Form
Dehydrated powder (GF1007F, GF617F) and granulated (KL1007F)
Standard (ACC)
ISO 21567 (GF1007F / KL1007F)
Reference standards, GF617F
CP / EP / USP

Preparation

Preparation
GF1007F / KL1007F: suspend 51.5 g in 1 L purified water, boil to dissolve, autoclave at 121 °C for 15 min. GF617F: suspend 50.0 g in 1 L purified water, boil to dissolve, autoclave at 121 °C for 15 min

Properties

Final pH (25 °C), all versions
7.1±0.2

Storage & handling

Storage
Store in a dark, dry place at 2-25 °C; tighten the bottle cap immediately after use.
Shelf life (sealed product)
3 years
Precautions
Not for clinical use. Do not use if the powder is lumpy. After use, autoclave all contaminated materials at 121 °C for 30 minutes before disposal.

Composition (GF1007F / KL1007F)

Enzymatic Digest of Casein and Animal Tissues
20.0 g/L
Lactose
10.0 g/L
Bile Salts No.3
1.5 g/L
Sodium Chloride
5.0 g/L
Neutral Red
0.03 g/L
Crystal Violet
0.001 g/L
Agar
15.0 g/L

Composition (GF617F)

Pancreatic Digest of Gelatin
17.0 g/L
Peptones
3.0 g/L
Lactose
10.0 g/L
Bile Salts
1.5 g/L
Sodium Chloride
5.0 g/L
Neutral Red
0.03 g/L
Crystal Violet
0.001 g/L
Agar
13.5 g/L
Features

Key features

  • 01

    Enteric bacilli differentiation

    GF1007F / KL1007F separate lactose-fermenting from lactose-non-fermenting Gram-negative enteric bacilli (ISO 21567).

  • 02

    Pharmaceutical E. coli isolation

    GF617F is listed for selective isolation of Escherichia coli in pharmaceutical products (CP/EP/USP).

  • 03

    Powder or granulated

    The general formulation is available as dehydrated powder (GF1007F) or granulated medium (KL1007F).

  • 04

    Defined selective system

    Bile salts, neutral red and crystal violet are included in every version; final pH is 7.1±0.2.

  • 05

    Three-year shelf life

    Sealed product keeps for 3 years when stored dark and dry at 2-25 °C.

From order to operation

We stay with the instrument after it arrives

Al-Shaker specifies the configuration, documents the system, and supports it across Jordan, the GCC, and MENA.

  1. 01

    Consult

  2. 02

    Plan

  3. 03

    Supply

  4. 04

    Install

  5. 05

    Train

  6. 06

    Support

Talk to the technical team

Tell us the application. We will specify the system.

Share the workflow, capacity, and compliance constraints. We respond with a recommended configuration, not a generic catalogue list.